Leukemia Research
Volume 28, Issue 3 , Pages 315-319, March 2004

Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy

Department of Pediatrics and Developmental Biology, Graduate School, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo 113-8519, Japan

Received 4 March 2003; accepted 25 June 2003.

Abstract 

Monosomy 7 syndrome in infant is considered as pre-leukemic condition of poor prognosis. However, it seems controversial recently, because some cases of monosomy 7 syndrome showed spontaneous remission. We report 2-year-old girl with severe pancytopenia, who presented with monosomy 7. Morphologically, there was little dysplasia in the trilineage hematopoiesis. Monosomy 7 clone of CD34 positive cells, bone marrow mononuclear cells (BMMNC), and peripheral nuclear cells was 4.0, 40, and 3.8%, respectively. Immunosuppressive therapy was effective along with the disappearance of monosomy 7 clone. WT1 mRNA expression was not increased in monosomy 7 clone. Pathogenesis of monosomy 7 and its relation to aplastic anemia is discussed.

Abbreviations:  CsA, cyclosporine A, ATG, anti-thymocyte globulin, WT1, Wilm’s tumor gene 1, JMML, juvenile myelomonocytic leukemia, MDS, myelodysplastic syndrome, G-CSF, granulocyte colony stimulating factor, PA-IgG, platelet-associated immunoglobulin G

Keywords:  Monosomy 7, Aplastic anemia, WT1, Cyclosporine A

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(03)00263-7

doi:10.1016/S0145-2126(03)00263-7

Leukemia Research
Volume 28, Issue 3 , Pages 315-319, March 2004